News Focus
News Focus
Followers 232
Posts 26887
Boards Moderated 0
Alias Born 01/12/2013

Re: studythosestocks post# 269155

Saturday, 04/25/2020 8:01:50 PM

Saturday, April 25, 2020 8:01:50 PM

Post# of 448117
Study-

With 2 very favorable judges then our odds may come around to 60-65% IMO and we won’t know that until the day of oral arguments.



Your email to JT is further enabling management agenda of ‘how can I get really rich‘. These asses had an opportunity to settle with both Hikma and Ready...they flat out refused! Can I prove they refused? Absolutely....no deal was made! Management could have offered an earlier entry into R-I as bait....they failed...or refused...either way incompetence is the only defining word that accurately describes the lack of settlement.

Management had a bonus scheduled to include protection of IP...? Unclear at this moment, but that’s something I want answered!

I love Vascepa but hate Amarin! Management is absolutely incompetent and that includes JT letting Kennedy drive “strategy”; only mistake after mistake following refusal to litigate ACHOR SPA rescindment. AMARIN was ONLY toting big pharmaceutical First Amendment agenda!!! Only reasons why they didn’t protect AMRN longs, sucking up to BP agenda and attempting to enrich themselves in a clean IP win!

Mistake after mistake...an appeal win odds is less than 25%! Facts are diluted by Judge Du decision and her appeal record of less than 10% reversal.

Consider sending JT a second email.

BB


If you're not good at being yourself, then maybe that's being yourself!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News